A 0 1 0 1 O
leukemia 2 10 2 10 B-cancer
- 10 11 10 11 O
specific 11 19 11 19 O
phenotype 20 29 20 29 O
( 30 31 30 31 O
e.g. 31 35 31 35 O
expression 36 46 36 46 O
of 47 49 47 49 O
markers 50 57 50 57 O
including 58 67 58 67 O
CD10 68 72 68 72 O
and/or 73 79 73 79 O
CD19 80 84 80 84 O
or 85 87 85 87 O
CD3 88 91 88 91 O
and/or 92 98 92 98 O
CD4 99 102 99 102 O
or 103 105 103 105 O
CD8 106 109 106 109 O
) 109 110 109 110 O
post 111 115 111 115 B-treatment
- 115 116 115 116 I-treatment
transplant 116 126 116 126 I-treatment
at 127 129 127 129 O
a 130 131 130 131 O
level 132 137 132 137 O
greater 138 145 138 145 O
than 146 150 146 150 O
or 151 153 151 153 O
equal 154 159 154 159 O
to 160 162 160 162 O
0.01 163 167 163 167 B-lower_bound
% 167 168 167 168 I-lower_bound

AST 0 3 169 172 B-clinical_variable
less 4 8 173 177 O
than 9 13 178 182 O
or 14 16 183 185 O
equal 17 22 186 191 O
to 23 25 192 194 O
3X 26 28 195 197 B-upper_bound
upper 29 34 198 203 I-upper_bound
limit 35 40 204 209 I-upper_bound
of 41 43 210 212 I-upper_bound
normal 44 50 213 219 I-upper_bound

Adjuvant 0 8 220 228 B-treatment
therapy 9 16 229 236 I-treatment
for 17 20 237 240 O
ALL 21 24 241 244 B-cancer

Any 0 3 245 248 O
leukemia 4 12 249 257 B-cancer
- 12 13 257 258 O
specific 13 21 258 266 O
marker 22 28 267 273 O
( 29 30 274 275 O
such 30 34 275 279 O
as 35 37 280 282 O
t(12;21 38 45 283 290 O
) 45 46 290 291 O
; 46 47 291 292 O
t(9;22 48 54 293 299 O
) 54 55 299 300 O
or 56 58 301 303 O
t(4;11 59 65 304 310 O
) 65 66 310 311 O
) 66 67 311 312 O
documented 68 78 313 323 O
in 79 81 324 326 O
the 82 85 327 330 O
patient 86 93 331 338 O
's 93 95 338 340 O
leukemia 96 104 341 349 O
cells 105 110 350 355 O
pre 111 114 356 359 B-treatment
- 114 115 359 360 I-treatment
transplant 115 125 360 370 I-treatment
on 126 128 371 373 O
a 129 130 374 375 O
post 131 135 376 380 B-treatment
- 135 136 380 381 I-treatment
transplant 136 146 381 391 I-treatment
evaluation 147 157 392 402 O

Bilirubin 0 9 403 412 B-clinical_variable
less 10 14 413 417 O
than 15 19 418 422 O
or 20 22 423 425 O
equal 23 28 426 431 O
to 29 31 432 434 O
2X 32 34 435 437 B-upper_bound
upper 35 40 438 443 I-upper_bound
limit 41 46 444 449 I-upper_bound
of 47 49 450 452 I-upper_bound
normal 50 56 453 459 I-upper_bound

Currently 0 9 460 469 O
taking 10 16 470 476 O
corticosteroids 17 32 477 492 B-treatment
( 33 34 493 494 O
greater 34 41 494 501 O
than 42 46 502 506 O
0.5 47 50 507 510 B-lower_bound
mg 51 53 511 513 I-lower_bound
/ 53 54 513 514 I-lower_bound
kg 54 56 514 516 I-lower_bound
/ 56 57 516 517 O
day 57 60 517 520 O
prednisone 61 71 521 531 B-treatment
or 72 74 532 534 O
equivalent 75 85 535 545 O
) 85 86 545 546 O

Donors 0 6 547 553 O
for 7 10 554 557 O
allogeneic 11 21 558 568 B-treatment
( 22 23 569 570 O
i.e. 23 27 570 574 O
HLA 28 31 575 578 O
matched 32 39 579 586 O
or 40 42 587 589 O
mismatched 43 53 590 600 O
related 54 61 601 608 O
or 62 64 609 611 O
unrelated 65 74 612 621 O
) 74 75 621 622 O
stem 76 80 623 627 B-treatment
cell 81 85 628 632 I-treatment
transplants 86 97 633 644 I-treatment
who 98 101 645 648 O
have 102 106 649 653 O
fulfilled 107 116 654 663 O
eligibility 117 128 664 675 O
for 129 132 676 679 O
and 133 136 680 683 O
consented 137 146 684 693 O
to 147 149 694 696 O
stem 150 154 697 701 B-treatment
cell 155 159 702 706 I-treatment
donation 160 168 707 715 I-treatment
as 169 171 716 718 O
per 172 175 719 722 O
the 176 179 723 726 O
stem 180 184 727 731 O
cell 185 189 732 736 O
transplant 190 200 737 747 O
program 201 208 748 755 O
's 208 210 755 757 O
standard 211 219 758 766 O
operating 220 229 767 776 O
procedures 230 240 777 787 O

Evidence 0 8 788 796 O
of 9 11 797 799 O
GVHD 12 16 800 804 B-chronic_disease
greater 17 24 805 812 O
than 25 29 813 817 O
Grade 30 35 818 823 B-lower_bound
II 36 38 824 826 I-lower_bound

Hgb 0 3 827 830 B-clinical_variable
greater 4 11 831 838 O
than 12 16 839 843 O
or 17 19 844 846 O
equal 20 25 847 852 O
to 26 28 853 855 O
7.0 29 32 856 859 B-lower_bound
g 33 34 860 861 I-lower_bound
/ 34 35 861 862 I-lower_bound
dL 35 37 862 864 I-lower_bound
( 38 39 865 866 O
can 39 42 866 869 O
be 43 45 870 872 O
transfused 46 56 873 883 O
) 56 57 883 884 O

Karnofsky 0 9 885 894 B-clinical_variable
/ 9 10 894 895 O
Lansky 10 16 895 901 B-clinical_variable
score 17 22 902 907 I-clinical_variable
of 23 25 908 910 O
greater 26 33 911 918 O
than 34 38 919 923 O
or 39 41 924 926 O
equal 42 47 927 932 O
to 48 50 933 935 O
50 51 53 936 938 B-lower_bound

Less 0 4 939 943 O
than 5 9 944 948 O
30 10 12 949 951 B-upper_bound
days 13 17 952 956 I-upper_bound
post 18 22 957 961 B-treatment
- 22 23 961 962 I-treatment
allogeneic 23 33 962 972 I-treatment
stem 34 38 973 977 I-treatment
cell 39 43 978 982 I-treatment
transplant 44 54 983 993 I-treatment

Life 0 4 994 998 B-clinical_variable
expectancy 5 15 999 1009 I-clinical_variable
greater 16 23 1010 1017 O
than 24 28 1018 1022 O
or 29 31 1023 1025 O
equal 32 37 1026 1031 O
to 38 40 1032 1034 O
6 41 42 1035 1036 B-lower_bound
weeks 43 48 1037 1042 I-lower_bound

Male 0 4 1043 1047 B-gender
partner 5 12 1048 1055 O
should 13 19 1056 1062 O
use 20 23 1063 1066 O
a 24 25 1067 1068 O
condom 26 32 1069 1075 O

Mixed 0 5 1076 1081 B-clinical_variable
donor 6 11 1082 1087 I-clinical_variable
chimerism 12 21 1088 1097 I-clinical_variable
( 22 23 1098 1099 O
greater 23 30 1099 1106 O
than 31 35 1107 1111 O
20 36 38 1112 1114 B-lower_bound
% 38 39 1114 1115 I-lower_bound
) 39 40 1115 1116 O

No 0 2 1117 1119 O
other 3 8 1120 1125 O
investigational 9 24 1126 1141 B-treatment
anti 25 29 1142 1146 I-treatment
- 29 30 1146 1147 I-treatment
neoplastic 30 40 1147 1157 I-treatment
therapy 41 48 1158 1165 I-treatment
for 49 52 1166 1169 O
one 53 56 1170 1173 B-upper_bound
month 57 62 1174 1179 I-upper_bound
prior 63 68 1180 1185 I-upper_bound
to 69 71 1186 1188 O
entry 72 77 1189 1194 O
in 78 80 1195 1197 O
this 81 85 1198 1202 O
study 86 91 1203 1208 O

Only 0 4 1209 1213 O
patients 5 13 1214 1222 O
who 14 17 1223 1226 O
receive 18 25 1227 1234 O
infusions 26 35 1235 1244 O
in 36 38 1245 1247 O
the 39 42 1248 1251 O
integrated 43 53 1252 1262 B-treatment
Cell 54 58 1263 1267 I-treatment
and 59 62 1268 1271 I-treatment
Gene 63 67 1272 1276 I-treatment
Therapy 68 75 1277 1284 I-treatment
( 76 77 1285 1286 I-treatment
CAGT 77 81 1286 1290 I-treatment
) 81 82 1290 1291 I-treatment
Transplant 83 93 1292 1302 I-treatment
program 94 101 1303 1310 I-treatment
at 102 104 1311 1313 O
Texas 105 110 1314 1319 O
Children 111 119 1320 1328 O
's 119 121 1328 1330 O
Hospital 122 130 1331 1339 O
( 131 132 1340 1341 O
TCH 132 135 1341 1344 O
) 135 136 1344 1345 O
or 137 139 1346 1348 O
Houston 140 147 1349 1356 O
Methodist 148 157 1357 1366 O
Hospital 158 166 1367 1375 O
( 167 168 1376 1377 O
HMH 168 171 1377 1380 O
) 171 172 1380 1381 O

Patients 0 8 1382 1390 O
receiving 9 18 1391 1400 O
ATG 19 22 1401 1404 B-treatment
or 23 25 1405 1407 O
Campath 26 33 1408 1415 B-treatment
within 34 40 1416 1422 O
28 41 43 1423 1425 B-upper_bound
days 44 48 1426 1430 I-upper_bound
of 49 51 1431 1433 O
infusion 52 60 1434 1442 O

Patients 0 8 1443 1451 O
receiving 9 18 1452 1461 O
a 19 20 1462 1463 O
Donor 21 26 1464 1469 B-treatment
Lymphocyte 27 37 1470 1480 I-treatment
Infusion 38 46 1481 1489 I-treatment
( 47 48 1490 1491 I-treatment
DLI 48 51 1491 1494 I-treatment
) 51 52 1494 1495 I-treatment
within 53 59 1496 1502 O
4 60 61 1503 1504 B-upper_bound
weeks 62 67 1505 1510 I-upper_bound
of 68 70 1511 1513 O
planned 71 78 1514 1521 O
T 79 80 1522 1523 B-treatment
cell 81 85 1524 1528 I-treatment
infusion 86 94 1529 1537 I-treatment

Patients 0 8 1538 1546 O
will 9 13 1547 1551 O
be 14 16 1552 1554 O
eligible 17 25 1555 1563 O
to 26 28 1564 1566 O
receive 29 36 1567 1574 O
donor 37 42 1575 1580 O
- 42 43 1580 1581 O
derived 43 50 1581 1588 O
multiTAA 51 59 1589 1597 O
- 59 60 1597 1598 O
specific 60 68 1598 1606 O
T 69 70 1607 1608 O
cells 71 76 1609 1614 O
following 77 86 1615 1624 O
any 87 90 1625 1628 O
type 91 95 1629 1633 O
of 96 98 1634 1636 O
allogeneic 99 109 1637 1647 B-treatment
HSCT 110 114 1648 1652 I-treatment

Pregnant 0 8 1653 1661 B-pregnancy

Pulse 0 5 1662 1667 B-clinical_variable
oximetry 6 14 1668 1676 I-clinical_variable
of 15 17 1677 1679 O
greater 18 25 1680 1687 O
than 26 30 1688 1692 O
90 31 33 1693 1695 B-lower_bound
% 33 34 1695 1696 I-lower_bound
on 35 37 1697 1699 O
room 38 42 1700 1704 O
air 43 46 1705 1708 O

Residual 0 8 1709 1717 B-cancer
disease 9 16 1718 1725 I-cancer
at 17 19 1726 1728 O
the 20 23 1729 1732 O
time 24 28 1733 1737 O
of 29 31 1738 1740 O
transplant 32 42 1741 1751 B-treatment
or 43 45 1752 1754 O
post 46 50 1755 1759 B-treatment
- 50 51 1759 1760 I-treatment
transplant 51 61 1760 1770 I-treatment
relapse 62 69 1771 1778 I-treatment
is 70 72 1779 1781 O
defined 73 80 1782 1789 O
as 81 83 1790 1792 O
PCR 84 87 1793 1796 B-treatment
positivity 88 98 1797 1807 O
, 98 99 1807 1808 O
specific 100 108 1809 1817 O
cytogenetic 109 120 1818 1829 O
abnormalities 121 134 1830 1843 O
, 134 135 1843 1844 O
an 136 138 1845 1847 O
abnormal 139 147 1848 1856 O
population 148 158 1857 1867 O
on 159 161 1868 1870 O
flow 162 166 1871 1875 O
cytometry 167 176 1876 1885 B-clinical_variable
, 176 177 1885 1886 O
or 178 180 1887 1889 O
increased 181 190 1890 1899 O
blasts 191 197 1900 1906 O
on 198 200 1907 1909 O
bone 201 205 1910 1914 B-treatment
marrow 206 212 1915 1921 I-treatment
biopsy 213 219 1922 1928 I-treatment
or 220 222 1929 1931 O
in 223 225 1932 1934 O
the 226 229 1935 1938 O
peripheral 230 240 1939 1949 O
blood 241 246 1950 1955 O

Serum 0 5 1956 1961 B-clinical_variable
creatinine 6 16 1962 1972 I-clinical_variable
less 17 21 1973 1977 O
than 22 26 1978 1982 O
or 27 29 1983 1985 O
equal 30 35 1986 1991 O
to 36 38 1992 1994 O
2X 39 41 1995 1997 B-upper_bound
upper 42 47 1998 2003 I-upper_bound
limit 48 53 2004 2009 I-upper_bound
of 54 56 2010 2012 I-upper_bound
normal 57 63 2013 2019 I-upper_bound

Severe 0 6 2020 2026 O
intercurrent 7 19 2027 2039 B-chronic_disease
infection 20 29 2040 2049 I-chronic_disease

Sexually 0 8 2050 2058 O
active 9 15 2059 2065 O
patients 16 24 2066 2074 O
must 25 29 2075 2079 O
be 30 32 2080 2082 O
willing 33 40 2083 2090 B-contraception_consent
to 41 43 2091 2093 I-contraception_consent
utilize 44 51 2094 2101 I-contraception_consent
one 52 55 2102 2105 I-contraception_consent
of 56 58 2106 2108 I-contraception_consent
the 59 62 2109 2112 I-contraception_consent
more 63 67 2113 2117 I-contraception_consent
effective 68 77 2118 2127 I-contraception_consent
birth 78 83 2128 2133 I-contraception_consent
control 84 91 2134 2141 I-contraception_consent
methods 92 99 2142 2149 I-contraception_consent
for 100 103 2150 2153 O
6 104 105 2154 2155 B-upper_bound
months 106 112 2156 2162 I-upper_bound
after 113 118 2163 2168 I-upper_bound
the 119 122 2169 2172 O
ATL 123 126 2173 2176 O
infusion 127 135 2177 2185 O

Treatment 0 9 2186 2195 B-treatment
for 10 13 2196 2199 O
relapsed 14 22 2200 2208 O
/ 22 23 2208 2209 O
residual 23 31 2209 2217 O
ALL 32 35 2218 2221 B-cancer
disease 36 43 2222 2229 O

